Scancell's Other Investors

Scancell raised a round of funding on , . Investors include Oxford Capital Partners.

Scancell is developing products that stimulate the immune system to treat or prevent cancer. The Company has four therapeutic antibodies in development and a pipeline of improved cancer vaccines based…

Articles about Scancell's Other Investors: